Angiolab, Inc. (XKON:251280)
2,490.00
+290.00 (13.18%)
At close: Oct 23, 2026
| Market Cap | 8.69B -40.4% |
| Revenue (ttm) | 702.62M -20.0% |
| Net Income | -1.19B |
| EPS | -1,356.00 |
| Shares Out | 3.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 211 |
| Open | 2,220.00 |
| Previous Close | 2,200.00 |
| Day's Range | 2,220.00 - 2,490.00 |
| 52-Week Range | 1,523.00 - 4,635.00 |
| Beta | -0.21 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |